LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 3 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 3. - Dataset (ID:20311)

 Full screen view
Filter results: >>>>
Cell Small Molecule Small Mol Concentration (uM) Time Point (hr) Total Cell Count Before Treatment Total Cell Count After Treatment Total Control Cell Count Relative Cell Count Normalized Growth Rate Inhibition Value Assay Plate Assay Well
MCF 10A-H2B-mCherry Trametinib
0.001
 33.32 84.90 2234 2722 0.8206 0.9225
MN20160318_Q02
N21
MCF 10A-H2B-mCherry Trametinib
0.001
 35.03 84.90 96 2991 0.0321 0.0242
MN20160318_Q02
E22
MCF 10A-H2B-mCherry Trametinib
0.001
 35.03 84.90 2110 2991 0.7054 0.8687
MN20160318_Q02
E22
MCF 10A-H2B-mCherry Trametinib
0.001
 35.03 84.90 224 2991 0.0749 0.2078
MN20160318_Q02
N21
MCF 10A-H2B-mCherry Trametinib
0.001
 35.03 84.90 2355 2991 0.7873 0.9091
MN20160318_Q02
N21
MCF 10A-H2B-mCherry Trametinib
0.001
 36.73 84.90 101 3254 0.0310 0.0336
MN20160318_Q02
E22
MCF 10A-H2B-mCherry Trametinib
0.001
 36.73 84.90 2255 3254 0.6929 0.8653
MN20160318_Q02
E22
MCF 10A-H2B-mCherry Trametinib
0.001
 36.73 84.90 283 3254 0.0870 0.2572
MN20160318_Q02
N21
MCF 10A-H2B-mCherry Trametinib
0.001
 36.73 84.90 2522 3254 0.7750 0.9054
MN20160318_Q02
N21
MCF 10A-H2B-mCherry Trametinib
0.001
 38.43 84.90 119 3459 0.0344 0.0652
MN20160318_Q02
E22
MCF 10A-H2B-mCherry Trametinib
0.001
 38.43 84.90 2348 3459 0.6787 0.8602
MN20160318_Q02
E22
MCF 10A-H2B-mCherry Trametinib
0.001
 38.43 84.90 302 3459 0.0873 0.2678
MN20160318_Q02
N21
MCF 10A-H2B-mCherry Trametinib
0.001
 38.43 84.90 2655 3459 0.7674 0.9034
MN20160318_Q02
N21
MCF 10A-H2B-mCherry Trametinib
0.001
 40.14 84.90 134 3682 0.0364 0.0875
MN20160318_Q02
E22
MCF 10A-H2B-mCherry Trametinib
0.001
 40.14 84.90 2527 3682 0.6863 0.8663
MN20160318_Q02
E22
MCF 10A-H2B-mCherry Trametinib
0.001
 40.14 84.90 313 3682 0.0850 0.2711
MN20160318_Q02
N21
MCF 10A-H2B-mCherry Trametinib
0.001
 40.14 84.90 2814 3682 0.7642 0.9035
MN20160318_Q02
N21
MCF 10A-H2B-mCherry Trametinib
0.001
 41.84 84.90 151 4003 0.0377 0.1091
MN20160318_Q02
E22
MCF 10A-H2B-mCherry Trametinib
0.001
 41.84 84.90 2666 4003 0.6660 0.8590
MN20160318_Q02
E22
MCF 10A-H2B-mCherry Trametinib
0.001
 41.84 84.90 374 4003 0.0934 0.3057
MN20160318_Q02
N21
MCF 10A-H2B-mCherry Trametinib
0.001
 41.84 84.90 2968 4003 0.7414 0.8952
MN20160318_Q02
N21
MCF 10A-H2B-mCherry Trametinib
0.001
 43.55 84.90 175 4287 0.0408 0.1364
MN20160318_Q02
E22
MCF 10A-H2B-mCherry Trametinib
0.001
 43.55 84.90 2835 4287 0.6612 0.8590
MN20160318_Q02
E22
MCF 10A-H2B-mCherry Trametinib
0.001
 43.55 84.90 401 4287 0.0935 0.3157
MN20160318_Q02
N21
MCF 10A-H2B-mCherry Trametinib
0.001
 43.55 84.90 3141 4287 0.7325 0.8930
MN20160318_Q02
N21